Simultaneous Integrated Boost Plan Comparison between Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Radiation Therapy (IMRT) for Prostate, Seminal vesicle and Lymph Node Irradiation
Objectives: We performed a planning study to evaluate the dosimetric differences between Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Radiation Therapy (IMRT) using simultaneous Integrated Boost (SIB) for prostate cancer cases.
Methods: 20 prostate cancer patients scheduled for SIB-VMAT treatment on the HalcyonTM 2.0 linear accelerator were recruited for this study and SIB-IMRT plans were generated for comparison purpose. The pelvic lymph nodes (PTV46), the seminal vesicle (PTV50), and the prostate (PTV60) were simultaneously treated to 46 Gy 50 Gy, and 60 Gy delivered in 20 fractions respectively.
Results: SIB-VMAT was better due to its higher (1.41%) CI, lower (2.7%) HI, and lower (26%) GI than SIB-IMRT for PTV60. For PTV50, a higher (7.3%) CI, lower (48%) HI, and a lower (31.73%) GI for SIB-VMAT compared to SIB-IMRT. Also, for PTV46, a higher (9.4%) CI, lower (2.5%) HI, and a lower (16.4%) GI were achieved by SIB-VMAT compared to SIB-IMRT.
Conclusion: Better conformal and slightly similar homogeneous dose distribution were noticed in SIB-VMAT plans compared to SIB-IMRT plans. However, SIB-IMRT provided better OARs sparing of the bladder and the femoral heads while SIB-VMAT had better sparing for rectum.
1. Jayadevappa R, Chhatre S, Wong YN, Wittink MN, Cook R, Morales KH, et al. Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant). Medicine (Baltimore) 2017;96:e6790.
2. Khan FM, Gibbons JP. Khan’s the physics of radiation therapy. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
3. Shang Q, Shen ZL, Ward MC, Joshi NP, Koyfman SA, Xia P. Evolution of treatment planning techniques in external-beam radiation therapy for head and neck cancer. App Radiat Oncol; 2015. Available at: https://appliedradiationoncology.com/articles/evolution-of-treatment-planning-techniques-in-external-beam-radiation-therapy-for-head-and-neck-cancer. Accessed Sep 20, 2022.
4. Kopp RW, Duff M, Catalfamo F, Shah D, Rajecki M, Ahmad K. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample. Med Dosim 2011;36:365–72.
5. Yuan L, Ge Y, Lee WR, Yin FF, Kirkpatrick JP, Wu QJ. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans. Med Phys 2012;39:6868–78.
6. Mellon EA, Javedan K, Strom TJ, Moros EG, Biagioli MC, Fernandez DC, et al. A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol 2015;5:11–5.
7. Yang W, Zeng B, Qiu Y, Tan J, Xu S, Cai Y, et al. A dosimetric comparison of dose escalation with simultaneous integrated boost for locally advanced non-small-cell lung cancer. Biomed Res Int 2017;2017:9736362.
8. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:996–1001.
9. Hardcastle N, Tomé WA, Foo K, Miller A, Carolan M, Metcalfe P. Comparison of prostate IMRT and VMAT biologically optimised treatment plans. Med Dosim 2011;36:292–8.
10. Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys 2012;83:1169–78.
11. Khan MI, Jiang R, Kiciak A, Ur Rehman J, Afzal M, Chow JC. Dosimetric and radiobiological characterizations of prostate intensity modulated radiotherapy and volumetric modulated arc therapy: A single institution review of ninety cases. J Med Phys 2016;41:270.
12. Crowe SB, Kairn T, Middlebrook N, Hill B, Christie DR, Knight RT, et al. Retrospective evaluation of dosimetric quality for prostate carcinomas treated with 3D conformal, intensity modulated and volumetric modulated arc radiotherapy. J Med Radiat Sci 2013;60:131–8.
13. Fogarty GB, Ng D, Liu G, Haydu LE, Bhandari N. Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy--a comparison among prostate cancer patients treated in an Australian centre. Radiat Oncol 2011;6:108.
14. Yoo S, Wu QJ, Lee WR, Yin FF. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes. Int J Radiat Oncol Biol Phys 2010;76:935–42.
15. Riou O, Regnault de la Mothe P, Azria D, Aillères N, Dubois JB, Fenoglietto P. Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer. J Appl Clin Med Phys 2013;14:4094.
16. Ost P, Speleers B, De Meerleer G, De Neve W, Fonteyne V, Villeirs G, et al. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study. Int J Radiat Oncol Biol Phys 2011;79:920–6.
17. Vergalasova I, Light K, Chino J, Craciunescu O. Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: Intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy. Med Dosim 2017;42:230–7.
18. Mukhtar R, Butt S, Rafaye MA, Iqbal K, Mazhar S, Sadaf T. An institutional review: Dosimetry comparison between simultaneous integrated boost IMRT and VMAT for prostate cancer. J Radiother Pract 2021;20:321–31.
19. Lee YK, Bedford JL, McNair HA, Hawkins MA. Comparison of deliverable IMRT and VMAT for spine metastases using a simultaneous integrated boost. Br J Radiol 2013;86:20120466.
20. Zhao J, Hu W, Cai G, Wang J, Xie J, Peng J, et al. Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost. Oncotarget 2016;7:6345–51.
21. Wu S, Lai Y, He Z, Zhou Y, Chen S, Dai M, et al. Dosimetric comparison of the simultaneous integrated boost in whole-breast irradiation after breast-conserving surgery: IMRT, IMRT plus an electron boost and VMAT. PLoS One 2015;10:e0120811.
22. Orlandi E, Palazzi M, Pignoli E, Fallai C, Giostra A, Olmi P. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review. Crit Rev Oncol Hematol 2010;73:111–25.
23. Pasquier D, Le Tinier F, Bennadji R, Jouin A, Horn S, Escande A, et al. Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life. Sci Rep 2019;9:2759.
24. Kim MM, Bollinger D, Kennedy C, Zou W, Scheuermann R, Teo BK, et al. Dosimetric Characterization of the dual layer MLC system for an O-Ring linear accelerator. Technol Cancer Res Treat 2019;18:1533033819883641.
25. Petroccia HM, Malajovich I, Barsky AR, Ghiam AF, Jones J, Wang C, et al. Spine SBRT with Halcyon™: Plan quality, modulation complexity, delivery accuracy, and speed. Front Oncol 2019;9:319.
26. Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006;64:333–42. 27. Agostinelli S, Garelli S, Gusinu M, Zeverino M, Cavagnetto F, Pupillo F, et al. Dosimetric analysis of Tomotherapy-based intracranial stereotactic radiosurgery of brain metastasis. Phys Med 2018;52:48–55.
28. Ohtakara K, Hayashi S, Hoshi H. Dose gradient analyses in Linac-based intracranial stereotactic radiosurgery using Paddick's gradient index: consideration of the optimal method for plan evaluation. J Radiat Res 2011;52:592–9.
29. Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg 2006;105:194–201.
30. Tsang YM, Hoskin P. The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients. Tech Innov Patient Support Radiat Oncol 2017;3–4:37–40.
31. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76:S10– 9.
32. Knöös T, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys 1998;42:1169–76.
33. The International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). Report 83. J ICRU 2010;10:1–106.
34. Chow JCL, Jiang R, Kiciak A, Markel D. Dosimetric comparison between the prostate intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) plans using the planning target volume (PTV) dose–volume factor. J Radiother Pract 2016;15:263–8.
35. Kyenzeh TL, Lenards N, Gutierrez AN, Zheng Shi. Simultaneous integrated boost plan comparison between static intensity-modulated radiotherapy and volumetric modulated arc therapy for prostate fossa and lymph node irradiation. Clin Oncol 2019;4:1667.
36. Jolly D, Alahakone D, Meyer J. A RapidArc planning strategy for prostate with simultaneous integrated boost. J Appl Clin Med Phys 2010;12:35–49.
37. Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009;93:226–33.